Pediatric Surgery International

, 26:3

ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective


  • Michela Pozzobon
    • Stem Cell Processing Laboratory, Department of PediatricsUniversity of Padova
  • Marco Ghionzoli
    • Surgery UnitUCL Institute of Child Health & Great Ormond St Hospital
    • Surgery UnitUCL Institute of Child Health & Great Ormond St Hospital
Review Article

DOI: 10.1007/s00383-009-2478-8

Cite this article as:
Pozzobon, M., Ghionzoli, M. & De Coppi, P. Pediatr Surg Int (2010) 26: 3. doi:10.1007/s00383-009-2478-8


Despite the advancements that have been made in treating infants with congenital malformations, these still represent a major cause of disease and death during the first years of life and childhood. Regeneration of natural tissue from living cells to restore damaged tissues and organs is the main purpose of regenerative medicine. This relatively new field has emerged by the combination of tissue engineering and stem cell transplantation as a possible strategy for the replacement of damaged organs or tissues. This review would like to offer an insight on the latest evolution of stem cells with a glance at their possible application for regenerative medicine, particularly in the Paediatric Surgery field.


Stem cellsRegenerative medicineESiPSMSCAFS cellsPediatric Surgery

Copyright information

© Springer-Verlag 2009